Literature DB >> 23243466

Should pregnant women with substance use disorders be managed differently?

Verena Metz1, Birgit Köchl, Gabriele Fischer.   

Abstract

Pregnant women with substance use disorders have multiple special needs, which might be best managed within a multiprofessional treatment setting involving medical, psychological and social care. Adequate treatment provision remains a challenge for healthcare professionals, who should undergo special training and education when working with this patient population. Careful assessment and screening is necessary to tailor interventions individually to the woman's needs in order to achieve beneficial clinical outcomes for mothers and newborns, whereas the choice of treatment options highly depends on the type of substance of abuse and evidence-based treatment interventions available. Economic considerations have shown that early multiprofessional treatment might yield better clinical outcomes and save healthcare costs over the lifespan.

Entities:  

Year:  2012        PMID: 23243466      PMCID: PMC3521595          DOI: 10.2217/npy.11.74

Source DB:  PubMed          Journal:  Neuropsychiatry (London)        ISSN: 1758-2008


  66 in total

Review 1.  Pharmacotherapy for pregnant women with addictions.

Authors:  William F Rayburn; Michael P Bogenschutz
Journal:  Am J Obstet Gynecol       Date:  2004-12       Impact factor: 8.661

2.  Neonatal drug withdrawal. American Academy of Pediatrics Committee on Drugs.

Authors: 
Journal:  Pediatrics       Date:  1998-06       Impact factor: 7.124

Review 3.  Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Committee on Drugs. American Academy of Pediatrics.

Authors: 
Journal:  Pediatrics       Date:  2000-04       Impact factor: 7.124

4.  Detecting alcoholism. The CAGE questionnaire.

Authors:  J A Ewing
Journal:  JAMA       Date:  1984-10-12       Impact factor: 56.272

5.  Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.

Authors:  Anthony J W Liu; Michael P Jones; Henry Murray; Colleen-Maree Cook; Ralph Nanan
Journal:  Aust N Z J Obstet Gynaecol       Date:  2010-06       Impact factor: 2.100

Review 6.  [Psychoactive substance use during pregnancy: a review].

Authors:  S Lamy; F Thibaut
Journal:  Encephale       Date:  2009-04-23       Impact factor: 1.291

7.  Sexually transmitted infections among pregnant heroin- or cocaine-addicted women in treatment: the significance of psychiatric co-morbidity and sex trade.

Authors:  C E Cavanaugh; S L Hedden; W W Latimer
Journal:  Int J STD AIDS       Date:  2010-02       Impact factor: 1.359

8.  Illicit drug use and adverse birth outcomes: is it drugs or context?

Authors:  Ashley H Schempf; Donna M Strobino
Journal:  J Urban Health       Date:  2008-09-15       Impact factor: 3.671

9.  A partner's drug-using status impacts women's drug treatment outcome.

Authors:  Michelle Tuten; Hendrée E Jones
Journal:  Drug Alcohol Depend       Date:  2003-06-05       Impact factor: 4.492

10.  Effects of voucher-based incentives on abstinence from cigarette smoking and fetal growth among pregnant women.

Authors:  Sarah H Heil; Stephen T Higgins; Ira M Bernstein; Laura J Solomon; Randall E Rogers; Colleen S Thomas; Gary J Badger; Mary Ellen Lynch
Journal:  Addiction       Date:  2008-06       Impact factor: 6.526

View more
  3 in total

1.  Determinants of syphilis infection among pregnant women attending antenatal care in hospitals of Wolaita zone, Southern Ethiopia, 2020.

Authors:  Tigabu Addisu Lendado; Tessema Tekle; Desalegn Dawit; Wakgari Binu Daga; Chala Wegi Diro; Mihiretu Alemayehu Arba; Tadese Tekle
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

2.  Motherhood, pregnancy and gateways to intervene in substance use disorder.

Authors:  Sugy Choi; Michael D Stein; Julia Raifman; David Rosenbloom; Jack A Clark
Journal:  Health Soc Care Community       Date:  2021-08-07

Review 3.  Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.

Authors:  Barbara K Zedler; Ashley L Mann; Mimi M Kim; Halle R Amick; Andrew R Joyce; E Lenn Murrelle; Hendrée E Jones
Journal:  Addiction       Date:  2016-06-30       Impact factor: 6.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.